Literature DB >> 17224423

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.

Houman Ashrafian1, Mark J Mason, Andrew G Mitchell.   

Abstract

The evolution of hypertrophic cardiomyopathy (HCM) towards dilatation and hypokinesis is an increasingly recognized complication with a high incidence of adverse outcomes, including sudden cardiac death, requiring defibrillator implantation and cardiac transplantation. It is generally regarded as the irreversible 'burnt-out' end-stage manifestation of HCM. We report one of the first cases of profound regression of the dilated-hypokinetic state by the application of biventricular pacing and cardiac resynchronization therapy (CRT). Reviewing the literature on the role of pacing in HCM and the energetic rationale for CRT in HCM prompts us to suggest that further systematic studies are needed urgently to assess the role of CRT in HCM variants.

Entities:  

Mesh:

Year:  2007        PMID: 17224423     DOI: 10.1093/europace/eul137

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Authors:  Lakshmi Sridharan; Brian Wayda; Lauren K Truby; Farhana Latif; Susan Restaino; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Paolo C Colombo; Mathew Maurer; Maryjane A Farr; Veli K Topkara
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

Review 2.  Hypertrophic cardiomyopathy: genetics and clinical perspectives.

Authors:  Cordula Maria Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

3.  Current management of hypertrophic cardiomyopathy.

Authors:  Caroline J Coats; Perry M Elliott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-12

4.  Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing.

Authors:  Christopher A Rinaldi; Senthil Kirubakaran; Clifford A Bucknall; Julian Bostock; Jaswinder S Gill
Journal:  Indian Pacing Electrophysiol J       Date:  2011-02-08

5.  Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.

Authors:  Yishay Wasserstrum; José M Larrañaga-Moreira; Cristina Martinez-Veira; Edward Itelman; Dor Lotan; Avi Sabbag; Rafael Kuperstein; Yael Peled; Dov Freimark; Roberto Barriales-Villa; Michael Arad
Journal:  ESC Heart Fail       Date:  2022-04-30

6.  "Burnt out" dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis.

Authors:  Cumaraswamy Sivathasan; Teing E E Tan; David Sim; Ka Lee Kerk
Journal:  Clin Case Rep       Date:  2015-04-09

7.  Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy.

Authors:  Yan Xiao; Kun-Qi Yang; Yan-Kun Yang; Ya-Xin Liu; Tao Tian; Lei Song; Xiong-Jing Jiang; Xian-Liang Zhou
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

8.  Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.

Authors:  Min Gu; Han Jin; Wei Hua; Xiao-Han Fan; Hong-Xia Niu; Tao Tian; Li-Gang Ding; Jing Wang; Cong Xue; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2017-04       Impact factor: 3.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.